Lipid storage myopathy
Lipid Storage Myopathy (LSM) is a group of metabolic disorders characterized by the abnormal accumulation of lipids in muscle cells. These conditions can lead to muscle weakness, fatigue, and in severe cases, significant muscle damage. LSM is caused by defects in the enzymes responsible for lipid metabolism, leading to an inability of the body to properly use fats as a source of energy for muscle activity.
Causes and Genetics[edit | edit source]
Lipid storage myopathies are caused by genetic mutations that affect the enzymes involved in the breakdown and utilization of lipids in the muscles. These mutations are typically inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific genes and enzymes involved can vary, leading to different subtypes of LSM.
Symptoms[edit | edit source]
The symptoms of lipid storage myopathy can vary widely among individuals but commonly include:
- Muscle weakness, particularly in the proximal muscles (those closest to the body's midline)
- Exercise intolerance
- Myalgia (muscle pain)
- Cramps
- Fatigue
In some cases, individuals may also experience cardiomyopathy, hepatomegaly (enlarged liver), or myoglobinuria (presence of muscle proteins in urine), especially after strenuous exercise.
Diagnosis[edit | edit source]
Diagnosis of lipid storage myopathy involves a combination of clinical evaluation, family history, and specialized tests, including:
- Blood tests to measure enzyme levels and detect markers of muscle damage
- Muscle biopsy to observe lipid accumulation in muscle cells
- Genetic testing to identify specific mutations
Treatment[edit | edit source]
There is no cure for lipid storage myopathy, but treatment focuses on managing symptoms and preventing muscle damage. Strategies may include:
- Dietary modifications to limit fat intake and avoid prolonged fasting
- Physical therapy to maintain muscle strength and mobility
- Medications to support energy metabolism in muscles
- Avoidance of strenuous exercise that can trigger symptoms
Prognosis[edit | edit source]
The prognosis for individuals with lipid storage myopathy varies depending on the subtype and severity of the condition. While some individuals may experience only mild symptoms and lead relatively normal lives, others may face significant physical limitations. Ongoing research into the underlying genetics and metabolism of LSM may lead to more effective treatments in the future.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD